Pharmacotherapeutic treatment options for recurrent epithelial ovarian cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacotherapeutic treatment options for recurrent epithelial ovarian cancer

Published:2022-08-29 Issue:1 Volume:24 Page:49-64
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Singh Nilanchali¹,Jayraj Aarthi S²,Sarkar Avir¹,Mohan Trishala¹,Shukla Amlin³,Ghatage Prafull⁴

Affiliation:

1. Department of Obstetrics and Gynaecology, AIIMS, New Delhi, India

2. Gynaecologic Oncology, Women’s Center, Coimbatore, India

3. Division of Reproductive Biology, Indian Council of Medical Research, New Delhi, India

4. Gynaecologic Oncology, Tom Baker Cancer Centre, Calgary, Alberta, Canada

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2022.2112030

Reference93 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials

3. Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial

4. Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma

5. A comparative analysis of prediction models for complete gross resection in secondary cytoreductive surgery for ovarian cancer

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deregulated circRNAs in Epithelial Ovarian Cancer With Activity in PreclinicalIn VivoModels: Identification of Targets and New Modalities for Therapeutic Intervention;Cancer Genomics - Proteomics;2024-04-26

2. Roles of TRPM7 in ovarian cancer;Biochemical Pharmacology;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3